Naturally split intein Npu DnaE mediated rapid generation of bispecific IgG antibodies

被引:16
作者
Han, Lei [1 ,3 ]
Zong, Huifang [1 ]
Zhou, Yuexian [1 ]
Pan, Zhidi [1 ]
Chen, Jie [1 ]
Ding, Kai [1 ]
Xie, Yueqing [2 ]
Jiang, Hua [2 ]
Zhang, Baohong [1 ]
Lu, Huili [1 ]
Gilly, John [3 ]
Zhu, Jianwei [1 ,2 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Pharm, Engn Res Ctr Cell & Therapeut Antibody, Minist Educ, Shanghai, Peoples R China
[2] Jecho Labs Inc, Frederick, MD USA
[3] Jecho Biopharmaceut Co Ltd, Tianjin, Peoples R China
关键词
Bispecific antibody; Protein engineering; Trans-splicing reaction; Split intein; Npu DnaE; EXPRESSION;
D O I
10.1016/j.ymeth.2018.10.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
High product purity, preserving natural IgG architecture, and excellent production efficiency are highly desirable in bispecific antibody manufacturing. We have reported a platform called Bispecific Antibody by Protein Trans-Splicing (BAPTS) to synthesize BsAbs with natural human IgG structure and no chain mispairing. In the method, two antibody fragments carrying different target-specificities are separately expressed in mammalian cells and subsequently fused to form BsAbs by utilizing the trans-splicing property of the split intein Npu DnaE. The hinge region of antibody, a region with less functional impact, is selected for conjugating the two fragments. The method involves the following steps: (i) constructing five plasmids coding antibody components; (ii) separately expressing and purifying two antibody fragments A and B. Fragment A contains one Fab, "Knobs-intoHoles" mutations in the CH3 domain and NPU DnaE(c). Fragment B contains another Fab and NPU DnaE(N); (iii) mixing of fragments A and B under permissive reducing conditions in vitro to enable trans-splicing reaction; (iv) removing the reluctant to allow re-oxidation of disulfide bonds; (v) isolating BsAb product from unreacted precursors by affinity chromatography. The method allows correct assembly of two heavy and two light chains to form bispecific IgG antibodies in natural structure with no synthetic linkers. No chain mispairing was observed in the product by UPLC-MASS. In addition, the observed kinetics and low reaction activation energy confirmed that the trans-splicing is thermodynamically favored reaction. The BAPTS technology is feasible for industrial applications.
引用
收藏
页码:32 / 37
页数:6
相关论文
共 21 条
[1]   Tumor regression in cancer patients by very low doses of a T cell-engaging antibody [J].
Bargou, Ralf ;
Leo, Eugen ;
Zugmaier, Gerhard ;
Klinger, Matthias ;
Goebeler, Mariele ;
Knop, Stefan ;
Noppeney, Richard ;
Viardot, Andreas ;
Hess, Georg ;
Schuler, Martin ;
Einsele, Hermann ;
Brandl, Christian ;
Wolf, Andreas ;
Kirchinger, Petra ;
Klappers, Petra ;
Schmidt, Margit ;
Riethmueller, Gert ;
Reinhardt, Carsten ;
Baeuerle, Patrick A. ;
Kufer, Peter .
SCIENCE, 2008, 321 (5891) :974-977
[2]   Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site [J].
Bostrom, Jenny ;
Yu, Shang-Fan ;
Kan, David ;
Appleton, Brent A. ;
Lee, Chingwei V. ;
Billeci, Karen ;
Man, Wenyan ;
Peale, Franklin ;
Ross, Sarajane ;
Wiesmann, Christian ;
Fuh, Germaine .
SCIENCE, 2009, 323 (5921) :1610-1614
[3]   Production process reproducibility and product quality consistency of transient gene expression in HEK293 cells with anti-PD1 antibody as the model protein [J].
Ding, Kai ;
Han, Lei ;
Zong, Huifang ;
Chen, Junsheng ;
Zhang, Baohong ;
Zhu, Jianwei .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2017, 101 (05) :1889-1898
[4]   Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system [J].
Han, Lei ;
Chen, Junsheng ;
Ding, Kai ;
Zong, Huifang ;
Xie, Yueqing ;
Jiang, Hua ;
Zhang, Baohong ;
Lu, Huili ;
Yin, Weihan ;
Gilly, John ;
Zhu, Jianwei .
SCIENTIFIC REPORTS, 2017, 7
[5]   Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity [J].
Huang, Yaoxing ;
Yu, Jian ;
Lanzi, Anastasia ;
Yao, Xin ;
Andrews, Chasity D. ;
Tsai, Lily ;
Gajjar, Mili R. ;
Sun, Ming ;
Seaman, Michael S. ;
Padte, Neal N. ;
Ho, David D. .
CELL, 2016, 165 (07) :1621-1631
[6]   Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies [J].
Klein, Christian ;
Sustmann, Claudio ;
Thomas, Markus ;
Stubenrauch, Kay ;
Croasdale, Rebecca ;
Schanzer, Juergen ;
Brinkmann, Ulrich ;
Kettenberger, Hubert ;
Regula, Joerg T. ;
Schaefer, Wolfgang .
MABS, 2012, 4 (06) :653-663
[7]   Optimized signal peptides for the development of high expressing CHO cell lines [J].
Kober, Lars ;
Zehe, Christoph ;
Bode, Juergen .
BIOTECHNOLOGY AND BIOENGINEERING, 2013, 110 (04) :1164-1173
[8]   Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange [J].
Labrijn, Aran F. ;
Meesters, Joyce I. ;
de Goeij, Bart E. C. G. ;
van den Bremer, Ewald T. J. ;
Neijssen, Joost ;
van Kampen, Muriel D. ;
Strumane, Kristin ;
Verploegen, Sandra ;
Kundu, Amitava ;
Gramer, Michael J. ;
van Berkel, Patrick H. C. ;
van de Winkel, Jan G. J. ;
Schuurman, Janine ;
Parren, Paul W. H. I. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (13) :5145-5150
[9]   Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface [J].
Lewis, Steven M. ;
Wu, Xiufeng ;
Pustilnik, Anna ;
Sereno, Arlene ;
Huang, Flora ;
Rick, Heather L. ;
Guntas, Gurkan ;
Leaver-Fay, Andrew ;
Smith, Eric M. ;
Ho, Carolyn ;
Hansen-Estruch, Christophe ;
Chamberlain, Aaron K. ;
Truhlar, Stephanie M. ;
Conner, Elaine M. ;
Atwell, Shane ;
Kuhlman, Brian ;
Demarest, Stephen J. .
NATURE BIOTECHNOLOGY, 2014, 32 (02) :191-+
[10]   An efficient route to human bispecific IgG [J].
Merchant, AM ;
Zhu, ZP ;
Yuan, JQ ;
Goddard, A ;
Adams, CW ;
Presta, LG ;
Carter, P .
NATURE BIOTECHNOLOGY, 1998, 16 (07) :677-681